Stargazer Pharmaceuticals

Provider of therapeutics for Stargardt disease

placeBoston, Massachusetts, United States calendar_todayFounded 2020 language stargazerpharmaceuticals.com

Innovation

1 patent family — focus: Human necessities; filing pace slowing. Cited 4 times.

YearFilings
20221

Investor mix

5 investors on record; lead investors include Novo Holdings, VenBio, Canaan, Pontifax.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%
Coming soon